Literature DB >> 12423791

High level expression of His-tagged colicin pore-forming domains and reflections on the sites for pore formation in the inner membrane.

Susan L Fridd1, Isa Gökçe, Jeremy H Lakey.   

Abstract

There exists ample evidence for the assumption that pore-forming colicins cannot exert their toxicity within the producing cell and that they must gain access to the outer face of the cytoplasmic membrane to achieve this. We wished to construct pET-vectors to produce pore-forming domains of colicin A and N with N-terminal hexa-histidine tags under the control of a T7 promoter. This was only possible when the correct immunity protein was also present. Hence it appears that this system exhibits the peculiarity that there is a toxicity associated with the over produced pore-forming domain. However, when the ratio of colicin to immunity protein is compared it is still clear that direct insertion into the cytoplasmic membrane does not occur and that membrane translocation of the colicin at limited sites may be occurring. This article reviews previous literature on the subject in terms of a model for limited sites of colicin action.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12423791     DOI: 10.1016/s0300-9084(02)01418-9

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  9 in total

1.  The Colicin E1 TolC Box: Identification of a Domain Required for Colicin E1 Cytotoxicity and TolC Binding.

Authors:  Karen S Jakes
Journal:  J Bacteriol       Date:  2016-12-13       Impact factor: 3.490

2.  Low resolution structure and dynamics of a colicin-receptor complex determined by neutron scattering.

Authors:  Luke A Clifton; Christopher L Johnson; Alexandra S Solovyova; Phil Callow; Kevin L Weiss; Helen Ridley; Anton P Le Brun; Christian J Kinane; John R P Webster; Stephen A Holt; Jeremy H Lakey
Journal:  J Biol Chem       Date:  2011-11-10       Impact factor: 5.157

3.  The Two-State Prehensile Tail of the Antibacterial Toxin Colicin N.

Authors:  Christopher L Johnson; Alexandra S Solovyova; Olli Hecht; Colin Macdonald; Helen Waller; J Günter Grossmann; Geoffrey R Moore; Jeremy H Lakey
Journal:  Biophys J       Date:  2017-10-17       Impact factor: 4.033

4.  A Natural Chimeric Pseudomonas Bacteriocin with Novel Pore-Forming Activity Parasitizes the Ferrichrome Transporter.

Authors:  Maarten G K Ghequire; Lieselore Kemland; Ernesto Anoz-Carbonell; Susan K Buchanan; René De Mot
Journal:  mBio       Date:  2017-02-21       Impact factor: 7.867

5.  Colicin N binds to the periphery of its receptor and translocator, outer membrane protein F.

Authors:  Thomas G Baboolal; Matthew J Conroy; Katrina Gill; Helen Ridley; Virak Visudtiphole; Per A Bullough; Jeremy H Lakey
Journal:  Structure       Date:  2008-03       Impact factor: 5.006

6.  The unstructured domain of colicin N kills Escherichia coli.

Authors:  Christopher L Johnson; Helen Ridley; Robert J Pengelly; Mohd Zulkifli Salleh; Jeremy H Lakey
Journal:  Mol Microbiol       Date:  2013-06-05       Impact factor: 3.501

7.  The antibacterial toxin colicin N binds to the inner core of lipopolysaccharide and close to its translocator protein.

Authors:  Christopher L Johnson; Helen Ridley; Roberta Marchetti; Alba Silipo; David C Griffin; Lucy Crawford; Boyan Bonev; Antonio Molinaro; Jeremy H Lakey
Journal:  Mol Microbiol       Date:  2014-03-28       Impact factor: 3.501

8.  The Effect of Lipopolysaccharide Core Oligosaccharide Size on the Electrostatic Binding of Antimicrobial Proteins to Models of the Gram Negative Bacterial Outer Membrane.

Authors:  Luke A Clifton; Filip Ciesielski; Maximilian W A Skoda; Nicolò Paracini; Stephen A Holt; Jeremy H Lakey
Journal:  Langmuir       Date:  2016-04-01       Impact factor: 3.882

9.  Bifurcated binding of the OmpF receptor underpins import of the bacteriocin colicin N into Escherichia coli.

Authors:  Katarina Bartoš Jansen; Patrick George Inns; Nicholas George Housden; Jonathan T S Hopper; Renata Kaminska; Sejeong Lee; Carol V Robinson; Hagan Bayley; Colin Kleanthous
Journal:  J Biol Chem       Date:  2020-05-12       Impact factor: 5.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.